GRIN1 mutations, and more broadly defects in the functionality of these glutamatergic neurons, are typically associated with cognitive impairments, epilepsy, microcephaly, muscular tone abnormalities, and behavior issues [60–63]. The gene discussed is GRIN1; the disease is epilepsy.